press-releases

Lunaphore closes a CHF 23M Series C financing round

Date

Lunaphore closes a CHF 23M Series C financing round

Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23M. The round was led by the Japanese strategic investor PHC Holdings Corporation, a global healthcare company that owns Epredia, a leading provider of comprehensive solutions for precision cancer diagnostics.

Read the full press release

Related Articles

Lunaphore – a Bio-Techne brand announces new data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, underscoring the potential of the COMET™ portfolio in cancer research
Lunaphore – a Bio-Techne brand announces new data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, underscoring the potential of the COMET™ portfolio in cancer research

Posted on 01 Nov 2023

Read Post
Lunaphore and ACD revolutionize spatial biology research with the launch of the first fully automated, same-section hyperplex multiomics application
Lunaphore and ACD revolutionize spatial biology research with the launch of the first fully automated, same-section hyperplex multiomics application

Posted on 25 Jan 2024

Read Post